PPAR Research · 2012 · 64 citations · 17 references
Rheum PalmatumCaloric RestrictionPrevents Diet-induced ObesityObesityMetabolic SyndromeMolecular PharmacologyMolecular NutritionFat WeightMetabolic SignalingCell SignalingHealth SciencesEnergy HomeostasisBiochemistryC57bl/6 MouseLipid NutritionPharmacologyCell BiologyMetabolic HealthPhysiologyMetabolic RegulationLipoprotein MetabolismMetabolismMedicineAntiobesity Role
Rheum palmatum has been used most frequently in the weight-reducing formulae in traditional Chinese medicine. However, the components of Rheum palmatum that play the antiobesity role are still uncertain. Here, we tested the weight-reducing effect of two major Rheum palmatum compounds on db/db mouse. We found that rhein (100 mg kg(-1) day(-1)), but not emodin, reduced the fat weight in db/db mouse. Using diet-induced obese (DIO) C57BL/6 mice, we identified that rhein blocked high-fat diet-induced obesity, decreased fat mass and the size of white and brown adipocytes, and lowered serum cholesterol, LDL cholesterol, and fasting blood glucose levels in the mice. To elucidate the underlying mechanisms, we used reporter assay and gene expression analysis and found that rhein inhibited peroxisome proliferator-activated receptor γ (PPARγ) transactivity and the expression of its target genes, suggesting that rhein may act as a PPARγ antagonist. Our data indicate that rhein may be a promising choice for antiobesity therapy.
17
David W. Haslam, W. P. T. James · The Lancet · 2005 · 3.8K citations
Christopher D. Cox, Michael J. Breslin, David B. Whitman et al. · Journal of Medicinal Chemistry · 2010 · 367 citations · Full text
Psychotropic Medication, Pharmacotherapy, Primary Insomnia +17